258 related articles for article (PubMed ID: 22189255)
1. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.
Spieldenner J; Belli D; Dupont C; Haschke F; Iskedjian M; Nevot Falcó S; Szajewska H; von Berg A
Ann Nutr Metab; 2011; 59 Suppl 1():44-52. PubMed ID: 22189255
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children.
Iskedjian M; Belli D; Farah B; Navarro V; Detzel P
J Med Econ; 2012; 15(2):378-93. PubMed ID: 22171935
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children.
Iskedjian M; Haschke F; Farah B; van Odijk J; Berbari J; Spieldenner J
J Med Econ; 2012; 15(2):394-408. PubMed ID: 22171936
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.
Su J; Prescott S; Sinn J; Tang M; Smith P; Heine RG; Spieldenner J; Iskedjian M
J Med Econ; 2012; 15(6):1064-77. PubMed ID: 22630113
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis.
Iskedjian M; Szajewska H; Spieldenner J; Farah B; Berbari J
Curr Med Res Opin; 2010 Nov; 26(11):2599-606. PubMed ID: 20925453
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children.
Iskedjian M; Dupont C; Spieldenner J; Kanny G; Raynaud F; Farah B; Haschke F
Curr Med Res Opin; 2010 Nov; 26(11):2607-26. PubMed ID: 20925454
[TBL] [Abstract][Full Text] [Related]
7. Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany.
Mertens J; Stock S; Lüngen M; von Berg A; Krämer U; Filipiak-Pittroff B; Heinrich J; Koletzko S; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D; Gerber A
Pediatr Allergy Immunol; 2012 Sep; 23(6):597-604. PubMed ID: 22624978
[TBL] [Abstract][Full Text] [Related]
8. Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.
Botteman MF; Bhanegaonkar AJ; Horodniceanu EG; Ji X; Lee BW; Shek LP; Van Bever HP; Detzel P
Singapore Med J; 2018 Aug; 59(8):439-448. PubMed ID: 29214323
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases.
Szajewska H; Horvath A
Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576
[TBL] [Abstract][Full Text] [Related]
10. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
11. Modified proteins in allergy prevention.
von Berg A
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():239-47; discussion 247-57. PubMed ID: 19710526
[TBL] [Abstract][Full Text] [Related]
12. Economic Burden of Atopic Dermatitis in High-Risk Infants Receiving Cow's Milk or Partially Hydrolyzed 100% Whey-Based Formula.
Bhanegaonkar A; Horodniceanu EG; Ji X; Detzel P; Boguniewicz M; Chamlin S; Lake A; Czerkies LA; Botteman MF; Saavedra JM
J Pediatr; 2015 May; 166(5):1145-1151.e3. PubMed ID: 25919724
[TBL] [Abstract][Full Text] [Related]
13. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis.
Alexander DD; Cabana MD
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):422-30. PubMed ID: 20216095
[TBL] [Abstract][Full Text] [Related]
14. Infant formulas containing hydrolysed protein for prevention of allergic disease.
Osborn DA; Sinn JK; Jones LJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003664. PubMed ID: 30338526
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.
Osborn DA; Sinn JK; Jones LJ
Cochrane Database Syst Rev; 2017 May; 5(5):CD003664. PubMed ID: 28542713
[TBL] [Abstract][Full Text] [Related]
16. Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.
Osborn DA; Sinn JK; Jones LJ
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003664. PubMed ID: 28293923
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants.
Bhanegaonkar AJ; Horodniceanu EG; Gonzalez RRH; Canlas Dizon MV; Detzel P; Erdogan-Ciftci E; Verheggen B; Botteman MF
Value Health Reg Issues; 2014 May; 3():124-135. PubMed ID: 29702918
[TBL] [Abstract][Full Text] [Related]
18. Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double-blind trial.
Szajewska H; Mrukowicz JZ; Stoińska B; Prochowska A
Acta Paediatr; 2004 Sep; 93(9):1159-65. PubMed ID: 15384877
[TBL] [Abstract][Full Text] [Related]
19. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.
Chung CS; Yamini S; Trumbo PR
Pediatrics; 2012 Aug; 130(2):e408-14. PubMed ID: 22778306
[TBL] [Abstract][Full Text] [Related]
20. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study.
von Berg A; Koletzko S; Filipiak-Pittroff B; Laubereau B; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
J Allergy Clin Immunol; 2007 Mar; 119(3):718-25. PubMed ID: 17240440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
